Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities (Q39925620)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 November 2009

Language	Label	Description	Also known as
English	Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities	scientific article published on 24 November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Anna A Frid

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Edwin J Matthews

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

24 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Regulatory Toxicology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

276-289

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Toxicological and clinical computational analysis and the US FDA/CDER.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Describing the validity of carcinogen screening tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Finding Discriminating Structural Features by Reassembling Common Building Blocks

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Cytochrome p450 in silico: an integrative modeling approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Signal Detectability and Medical Decision-Making

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in Rodents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Robust Classification for Imprecise Environments

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

LeadScope: software for exploring large sets of screening data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Drug-Induced Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.005

7 January 2021

Identifiers

10.1016/J.YRTPH.2009.11.005

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39925620&oldid=1878694870"